{"artifact":{"id":"wiki-clinical-trials-north-american-prodromal-synucleinopathy-consortium-nct05826457","artifact_type":"wiki_page","entity_ids":"[\"clinical-trials-north-american-prodromal-synucleinopathy-consortium-nct05826457\"]","title":"North American Prodromal Synucleinopathy Consortium (NAPOS) Stage 2 — NCT05826457","quality_score":0.5,"created_by":"crosslink-migration","provenance_chain":"[]","content_hash":"79da19a6b7e8530d345bdebe87a43a817760b5b55e9d566f31e74ee0cb76e5ca","metadata":{"slug":"clinical-trials-north-american-prodromal-synucleinopathy-consortium-nct05826457","kg_node_id":null,"entity_type":"clinical","origin_type":"v1_polymorphic_backfill","source_table":"wiki_pages","wiki_page_id":"wp-d78788d766a2","__merged_from":{"merged_at":"2026-05-13","unprefixed_id":"clinical-trials-north-american-prodromal-synucleinopathy-consortium-nct05826457"},"_schema_version":1},"created_at":"2026-04-02T07:19:04-07:00","updated_at":"2026-04-02T13:40:08-07:00","version_number":5,"parent_version_id":null,"version_tag":null,"changelog":null,"is_latest":1,"lifecycle_state":"active","superseded_by":null,"deprecated_at":null,"deprecated_reason":null,"dependencies":null,"market_price":0.5,"origin_type":"internal","origin_url":null,"lifecycle_changed_at":"2026-04-02T13:40:08-07:00","citation_count":0,"embed_count":0,"derivation_count":0,"support_count":0,"contradiction_count":0,"total_usage":0.0,"usage_score":0.5,"usage_computed_at":null,"quality_status":"ok","contributors":[],"answers_question_ids":null,"deprecated_reason_detail":null,"deprecated_reason_code":null,"commit_sha":null,"commit_submodule":null,"last_mutated_at":"2026-05-16T14:51:34.657673-07:00","disputed_at":null,"gap_id":null,"mission_id":null,"intrinsic_priority":null,"effective_priority":null,"artifact_id":"113d5675-c734-4e42-b00a-74205a56feee","artifact_dir":null,"primary_filename":null,"accessory_filenames":null,"folder_layout_version":1,"migrated_to_folder_at":null,"hypothesis_id":null,"authorship":{"kind":"human","contributors":[{"role":"author","actor_ref":"crosslink-migration"}]},"epistemic_tier":"T3_provisional","created_by_agent_id":null},"outgoing_links":[{"target_artifact_id":"experiment-exp-wiki-experiments-dlb-treatment-response-biomarkers","link_type":"mentions","strength":0.4,"evidence":null},{"target_artifact_id":"experiment-exp-wiki-experiments-dlb-alpha-synuclein-staging-spreading","link_type":"mentions","strength":0.4,"evidence":null},{"target_artifact_id":"experiment-exp-wiki-experiments-cgas-sting-parkinsons","link_type":"mentions","strength":0.4,"evidence":null},{"target_artifact_id":"experiment-exp-wiki-experiments-alpha-syn-saa-kinetics-pd","link_type":"mentions","strength":0.4,"evidence":null},{"target_artifact_id":"experiment-exp-wiki-experiments-non-motor-symptom-progression-pd","link_type":"mentions","strength":0.4,"evidence":null},{"target_artifact_id":"hypothesis-h-7bb47d7a","link_type":"mentions","strength":0.9,"evidence":"Wiki page mentions gene TH targeted by hypothesis"},{"target_artifact_id":"experiment-exp-wiki-experiments-macroautophagy-dysfunction-parkinsons","link_type":"related","strength":0.7,"evidence":"Wiki page for MA related to experiment"},{"target_artifact_id":"experiment-exp-wiki-experiments-er-golgi-secretory-pathway-parkinsons","link_type":"related","strength":0.7,"evidence":"Wiki page for ER related to experiment"},{"target_artifact_id":"experiment-exp-wiki-experiments-lipid-droplet-lysosome-axis-parkinsons","link_type":"related","strength":0.7,"evidence":"Wiki page for CT related to experiment"},{"target_artifact_id":"hypothesis-h-74777459","link_type":"related","strength":0.5,"evidence":"Wiki relates to pathway: Alpha-synuclein aggregation"},{"target_artifact_id":"analysis-SDA-2026-04-01-gap-20260401-225149","link_type":"related","strength":0.5,"evidence":"Auto: transitive via hypothesis"}],"incoming_links":[{"source_artifact_id":"hypothesis-h-7bb47d7a","link_type":"related","strength":0.9,"evidence":"Hypothesis targets gene TH described in wiki"},{"source_artifact_id":"experiment-exp-wiki-experiments-macroautophagy-dysfunction-parkinsons","link_type":"related","strength":0.7,"evidence":"Experiment targets MA described in wiki"},{"source_artifact_id":"experiment-exp-wiki-experiments-er-golgi-secretory-pathway-parkinsons","link_type":"related","strength":0.7,"evidence":"Experiment targets ER described in wiki"},{"source_artifact_id":"experiment-exp-wiki-experiments-lipid-droplet-lysosome-axis-parkinsons","link_type":"related","strength":0.7,"evidence":"Experiment targets CT described in wiki"},{"source_artifact_id":"analysis-SDA-2026-04-01-gap-20260401-225149","link_type":"related","strength":0.5,"evidence":"Reverse link"}],"current_artifact_id":"wiki-clinical-trials-north-american-prodromal-synucleinopathy-consortium-nct05826457","is_canonical":true,"supersede_chain":["wiki-clinical-trials-north-american-prodromal-synucleinopathy-consortium-nct05826457"]}